Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.
2.

Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.

Sellam J, Rouanet S, Hendel-Chavez H, Abbed K, Sibilia J, Tebib J, Le Loët X, Combe B, Dougados M, Mariette X, Taoufik Y.

Arthritis Rheum. 2011 Dec;63(12):3692-701. doi: 10.1002/art.30599.

3.

RF positivity has substantial influence on the peripheral memory B-cell compartment and its modulation by TNF inhibition.

Roll P, Muhammad K, Schumann M, Kleinert S, Tony HP.

Scand J Rheumatol. 2012 May;41(3):180-5. doi: 10.3109/03009742.2011.645056. Epub 2012 Mar 9.

PMID:
22400711
4.

Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.

Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, Anandarajah AP, Looney RJ, Thiele RG, Anolik JH, Coca A, Wei C, Rosenberg AF, Feng C, Treanor JJ, Lee FE, Sanz I.

Arthritis Res Ther. 2011;13(6):R209. doi: 10.1186/ar3542. Epub 2011 Dec 16.

5.

Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy.

Wright HL, Thomas HB, Moots RJ, Edwards SW.

Rheumatology (Oxford). 2015 Jan;54(1):188-93. doi: 10.1093/rheumatology/keu299. Epub 2014 Aug 13.

PMID:
25125592
6.

CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.

Sellam J, Rouanet S, Hendel-Chavez H, Miceli-Richard C, Combe B, Sibilia J, Le Loët X, Tebib J, Jourdan R, Dougados M, Taoufik Y, Mariette X.

Arthritis Rheum. 2013 Sep;65(9):2253-61. doi: 10.1002/art.38023.

7.

Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.

Picchianti Diamanti A, Rosado MM, Scarsella M, Germano V, Giorda E, Cascioli S, Laganà B, D'Amelio R, Carsetti R.

Clin Exp Immunol. 2014 Sep;177(3):630-40. doi: 10.1111/cei.12367.

8.

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response.

Nakou M, Katsikas G, Sidiropoulos P, Bertsias G, Papadimitraki E, Raptopoulou A, Koutala H, Papadaki HA, Kritikos H, Boumpas DT.

Arthritis Res Ther. 2009;11(4):R131. doi: 10.1186/ar2798. Epub 2009 Aug 28.

9.

B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status.

Michelutti A, Gremese E, Morassi F, Petricca L, Arena V, Tolusso B, Alivernini S, Peluso G, Bosello SL, Ferraccioli G.

Mol Med. 2011 Sep-Oct;17(9-10):901-9. doi: 10.2119/molmed.2011.00034. Epub 2011 May 13.

10.

Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis.

Fedele AL, Tolusso B, Gremese E, Bosello SL, Carbonella A, Canestri S, Ferraccioli G.

BMC Immunol. 2014 Sep 4;15:28. doi: 10.1186/s12865-014-0028-1.

11.

Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor.

Souto-Carneiro MM, Mahadevan V, Takada K, Fritsch-Stork R, Nanki T, Brown M, Fleisher TA, Wilson M, Goldbach-Mansky R, Lipsky PE.

Arthritis Res Ther. 2009;11(3):R84. doi: 10.1186/ar2718. Epub 2009 Jun 5.

12.

Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses.

Fekete A, Soos L, Szekanecz Z, Szabo Z, Szodoray P, Barath S, Lakos G.

J Autoimmun. 2007 Sep-Nov;29(2-3):154-63.

PMID:
17826949
13.

ZAP-70+ B cell subset influences response to B cell depletion therapy and early repopulation in rheumatoid arthritis.

Gremese E, Tolusso B, Fedele AL, Canestri S, Alivernini S, Ferraccioli G.

J Rheumatol. 2012 Dec;39(12):2276-85. doi: 10.3899/jrheum.120153. Epub 2012 Sep 15.

PMID:
22984268
14.

Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.

Rehnberg M, Amu S, Tarkowski A, Bokarewa MI, Brisslert M.

Arthritis Res Ther. 2009;11(4):R123. doi: 10.1186/ar2789. Epub 2009 Aug 17.

15.

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study.

Ljung L, Askling J, Rantapää-Dahlqvist S, Jacobsson L; ARTIS Study Group.

Arthritis Res Ther. 2014 Jun 18;16(3):R127. doi: 10.1186/ar4584.

16.

[THE IDENTIFICATION OF SUB-POPULATIONS OF B-LYMPHOCYTES OF PERIPHERAL BLOOD USING TECHNIQUE OF FLOW CYTOFLUOROMETRY IN HEALTHY INDIVIDUALS AND PATIENTS WITH RHEUMATOID DISEASES].

Suponitskaia EV, Aleksankin AP, Aleksandrova EN, Avdeeva AS, Panafidina TA, Verijnikova JG, Nasonov EL.

Klin Lab Diagn. 2015 Jun;60(6):30-3. Russian.

PMID:
26466448
17.

B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy.

de la Torre I, Moura RA, Leandro MJ, Edwards J, Cambridge G.

Ann Rheum Dis. 2010 Dec;69(12):2181-8. doi: 10.1136/ard.2010.131326. Epub 2010 Jun 25. Erratum in: Ann Rheum Dis. 2011 Jul;70(7):1350.

PMID:
20581016
18.

Determinants associated with work participation in patients with established rheumatoid arthritis taking tumor necrosis factor inhibitors.

Manders SH, Kievit W, Braakman-Jansen AL, Brus HL, Hendriks L, Fransen J, van de Laar MA, van Riel PL.

J Rheumatol. 2014 Jul;41(7):1263-9. doi: 10.3899/jrheum.130878. Epub 2014 May 15.

PMID:
24833758
19.

Changes in peripheral blood B cell subsets at diagnosis and after treatment with disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: correlation with clinical and laboratory parameters.

McComish J, Mundy J, Sullivan T, Proudman SM, Hissaria P.

Int J Rheum Dis. 2015 May;18(4):421-32. doi: 10.1111/1756-185X.12325. Epub 2014 Mar 2.

PMID:
24589014
20.

Class-switched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis.

Möller B, Aeberli D, Eggli S, Fuhrer M, Vajtai I, Vögelin E, Ziswiler HR, Dahinden CA, Villiger PM.

Arthritis Res Ther. 2009;11(3):R62. doi: 10.1186/ar2686. Epub 2009 May 6.

Supplemental Content

Support Center